Inventor
GOERGLER ANNICK
CH28 patents
⚠️ This page may combine multiple inventors who share the name “GOERGLER ANNICK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
C4 THERAPEUTICS INC
13 patentsUS11584748B2Feb 21, 2023
Spirocyclic compounds
C4 THERAPEUTICS INC11 citations85
US11254672B2Feb 22, 2022
Dihydrobenzimidazolones for medical treatment
C4 THERAPEUTICS INC7 citations84
US12371442B2Jul 29, 2025
Isoindolinone and indazole compounds for the degradation of EGFR
C4 THERAPEUTICS INC1 citations74
US11623929B2Apr 11, 2023
Spirocyclic compounds
C4 THERAPEUTICS INC7 citations74
US11802131B2Oct 31, 2023
Glutarimides for medical treatment
C4 THERAPEUTICS INC4 citations73
US11787802B2Oct 17, 2023
Dihydrobenzimidazolones for medical treatment
C4 THERAPEUTICS INC3 citations72
US11673902B2Jun 13, 2023
Isoindolinone and indazole compounds for the degradation of EGFR
C4 THERAPEUTICS INC3 citations72
US11401256B2Aug 2, 2022
Dihydroquinolinones for medical treatment
C4 THERAPEUTICS INC5 citations69
US12486290B2Dec 2, 2025
Isoindolinone and indazole compounds for the degradation of EGFR
C4 THERAPEUTICS INC0 citations62
US12227504B2Feb 18, 2025
Spirocyclic compounds
C4 THERAPEUTICS INC0 citations62
US12365681B2Jul 22, 2025
Dihydrobenzimidazolones for medical treatment
C4 THERAPEUTICS INC0 citations61
US12091397B2Sep 17, 2024
Dihydroquinolinones for medical treatment
C4 THERAPEUTICS INC1 citations58
US12528797B2Jan 20, 2026
Heterocyclic compounds for medical treatment
C4 THERAPEUTICS INC0 citations51
HOFFMANN LA ROCHE
10 patentsUS12209091B2Jan 28, 2025
Isoindolinone derivatives as selective allosteric inhibitors of Egfr mutant cancers
HOFFMANN LA ROCHE7 citations85
US7375099B2May 20, 2008
Malonamide derivatives
HOFFMANN LA ROCHE13 citations82
US12344613B2Jul 1, 2025
EGFR inhibitor for the treatment of cancer
HOFFMANN LA ROCHE3 citations72
US6482829B2Nov 19, 2002
Substituted heterocyclic siprodecane compound active as an antagonist of neurokinin 1 receptor
HOFFMANN LA ROCHE6 citations63
US11319314B2May 3, 2022
Phenoxytriazoles
HOFFMANN LA ROCHE1 citations62
US12479849B2Nov 25, 2025
EGFR inhibitors for the treatment of cancer
HOFFMANN LA ROCHE0 citations60
US12552801B2Feb 17, 2026
Indazole derivatives
HOFFMANN LA ROCHE0 citations59
US9181230B2Nov 10, 2015
Morpholine compounds and uses thereof
HOFFMANN LA ROCHE0 citations42
US6452001B2Sep 17, 2002
Diazapane derivatives useful as antagonists of neurokinin 1 receptor and methods for their formation
HOFFMANN LA ROCHE0 citations41
US9957261B2May 1, 2018
6-amino-5,6,7,8-tetrahydronaphthalen-2-yl or 3-aminochroman-7-yl derivatives
HOFFMANN LA ROCHE0 citations38
GALLEY GUIDO
4 patentsUS8729113B2May 20, 2014
4,5-dihydro-oxazol-2yl derivatives
GALLEY GUIDO0 citations51
US8586617B2Nov 19, 2013
Aminomethyl-4-imidazoles
GALLEY GUIDO1 citations51
US8389507B2Mar 5, 2013
2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as TAAR-ligands
GALLEY GUIDO0 citations51
US8242153B2Aug 14, 2012
4,5-dihydro-oxazol-2YL derivatives
GALLEY GUIDO0 citations51